Within Major Pharmaceutical Preparations industry Nascent Biotech Inc booked the highest Quick Ratio than Nascent Biotech Inc in the first quarter 2024. While total ranking remained the same in the Q1 2024 compared to the fourth quarter 2024 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents NBIO�s has?
What are NBIO�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NBIO Quick Ratio	(Jun 30 2024) Q1	(Mar 31 2024) Q4	(Dec 31 2023) Q3	(Sep 30 2023) Q2	(Jun 30 2023) Q1
Y / Y Current Liabilities Change	-39.88 %	-47.86 %	-68.46 %	-58.35 %	-23.83 %
Y / Y Cash & cash equivalent Change	-	-	-	-	-93.49 %
Quick Ratio MRQ	-	-	-	-	0.01
NBIO's Total Ranking	#	#	#	#	#
Seq. Current Liabilities Change	-8.27 %	32.86 %	-38.83 %	-19.36 %	-20.45 %
Seq. Cash & cash equivalent Change	-	-	-	-	-94.49 %

Quick Ratio first quarter 2024 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Quick Ratio Statistics
High	Average	Low
0	0	0

Financial Statements
Nascent Biotech Inc 's Current Liabilities	$ 1 Millions	Visit NBIO's Balance sheet
Nascent Biotech Inc 's Cash & cash equivalent	$ 0 Millions	Visit NBIO's Balance sheet
Source of NBIO's Sales		Visit NBIO's Sales by Geography

Cumulative Nascent Biotech Inc 's Quick Ratio

NBIO's Quick Ratio for the trailling 12 Months

NBIO Quick Ratio	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months
Y / Y Current Liabilities TTM Growth	-55.59 %	-51.31 %	-34.65 %	9.58 %	78.82 %
Y / Y Cash & cash equivalent TTM Growth	-	-99.54 %	-90.83 %	-47.99 %	458.64 %
Quick Ratio TTM	-	0	0.04	0.13	0.27
Total Ranking TTM		#	#	#	#
Seq. Current Liabilities TTM Growth	-13.49 %	-16.91 %	-23.14 %	-19.62 %	-5.15 %
Seq. Cash & cash equivalent TTM Growth	-	-94.78 %	-75.46 %	-61.48 %	-6.61 %

Quick ratio ranking by company, industry and sector >> Back to NBIO Financial Strength Comparisons >> Go to Compare NBIO Quick Ratio to its Competitors

On the trailing twelve months basis
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry NBIO achieved the highest Quick Ratio. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending fourth quarter 2024 at 2846.

Explain Quick Ratio?
How much Cash & cash equivalents NBIO�s has?
What are NBIO�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Within the Market	#

trailing twelve months Quick Ratio Statistics
High	Average	Low
0	0	0

Companies with similar Quick Ratio in the quarter ending Jun 30 2024, within Major Pharmaceutical Preparations Industry

Quick Ratio

Jun 30 2024 MRQ Cash & cash equivalent

Jun 30 2024 MRQ Current Liabilities

Date modified: 2026-09-08T15:11:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.